Effect of Low Level Laser Therapy on Orthodontic Miniscrew Displacement
Miniscrew
1 other identifier
interventional
12
1 country
2
Brief Summary
EFFECT OF LOW LEVEL LASER THERAPY ON ORTHODONTIC MINISCREW DISPLACEMENT
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2021
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 26, 2021
CompletedFirst Submitted
Initial submission to the registry
September 27, 2021
CompletedFirst Posted
Study publicly available on registry
October 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 7, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 5, 2022
CompletedNovember 17, 2021
November 1, 2021
6 months
September 27, 2021
November 9, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
effect of low level laser therapy on displacement of miniscrews
Miniscrews displacement will be assessed after four months of canine retraction using CBCT scan. The head and tail of miniscrew will be measured in relation to anterior nasal spine as a fixed reference point before and after retraction
4 months
Secondary Outcomes (1)
effect of LLL application on gingival condition around the miniscrew.
4 months
Study Arms (2)
Control
EXPERIMENTALWill have miniscrew only without laser application
Experimental
EXPERIMENTALWill have miniscrew and laser application
Interventions
Eligibility Criteria
You may qualify if:
- Patients aged 18 to 22 years old.
- Permanent dentition.
- Class I Bimaxillary protrusion and class II devision 1 patients.
- Good oral hygiene.
You may not qualify if:
- Medically compromised patients.
- Chronic renal failure and hormonal disorders as thyroid and parathyroid.
- Regular use of steroids, barbiturates, anticonvulsants drugs, and thyroid hormone replacements.
- Tobacco smoking.
- Any disease or metabolic disorder that can affect bone physiology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Alexandria University
Alexandria, Egypt
AlexandriaU
Alexandria, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mohamed A Elzoheiry
Alexandria University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
September 27, 2021
First Posted
October 25, 2021
Study Start
September 26, 2021
Primary Completion
April 7, 2022
Study Completion
May 5, 2022
Last Updated
November 17, 2021
Record last verified: 2021-11